title: Toxicology of environmental estrogens.
abstract: It has been hypothesized that environmental contaminants that modulate endocrine signaling pathways may be causally linked to adverse health effects in humans. There has been particular concern regarding synthetic estrogens and their role in disrupting normal development of the male reproductive tract. Most estrogenic industrial compounds, such as bisphenol A (BPA) and nonylphenol, typically bind estrogen receptors alpha (ERalpha) and beta (ERbeta) and induce transactivation of estrogen-responsive genes/reporter genes, but their potencies are usually > or = 1,000-fold lower than observed for 17beta-estradiol (E2). Selective estrogen receptor modulators (SERMs) represent another class of synthetic estrogens that are being developed for treatment of hormone-dependent problems. The SERMs differentially activate wild-type ERalpha and variant forms expressing activation function 1 (ER-AF1) and AF2 (ER-AF2) in human HepG2 hepatoma cells transfected with a pC3-luciferase construct, and these in vitro differences reflect their unique in vivo biologies. The HepG2 cell assay has also been used in our laboratories to investigate the estrogenic activities of the following structurally diverse synthetic and phytoestrogens: 4'-hydroxytamoxifen; BPA; 2',4',6'-trichloro-4-biphenylol; 2',3',4',5'-tetrachloro-4-biphenylol; p-t-octylphenol; p-nonylphenol; naringenin; kepone; resveratrol; and 2,2-bis(p-hydroxyphenyl)-1,1,1-trichloroethane (HPTE). The results show that synthetic and phytoestrogens induce distinct patterns of gene activation in HepG2 and U2 osteogenic sarcoma cells, suggesting that these compounds will induce tissue-specific in vivo ER agonist or antagonist activities. The predicted differences between these compounds, based on results of the in vitro bioassay, have been confirmed. For example, BPA inhibits E2-induced responses in the rodent uterus, and HPTE and structurally related compounds are ERalpha agonists and ERbeta antagonists in assays carried out in HepG2 and other cancer cell lines.
authors.affiliation: Department of Veterinary Physiology and Pharmacology, Texas A&M University, College Station 77843-4466, USA. ssafe@cvm.tamu.edu
authors.forename: S H
authors.initials: SH
authors.lastname: Safe
authors.forename: L
authors.initials: L
authors.lastname: Pallaroni
authors.forename: K
authors.initials: K
authors.lastname: Yoon
authors.forename: K
authors.initials: K
authors.lastname: Gaido
authors.forename: S
authors.initials: S
authors.lastname: Ross
authors.forename: B
authors.initials: B
authors.lastname: Saville
authors.forename: D
authors.initials: D
authors.lastname: McDonnellc
mesh_terms: D000818:Animals; D001559:Benzhydryl Compounds / Q000633:toxicity; D004032:Diet; D004781:Environmental Exposure; D020847:Estrogen Receptor Modulators / Q000633:toxicity; D047628:Estrogen Receptor alpha; D004967:Estrogens / Q000633:toxicity*; D004968:Estrogens, Non-Steroidal / Q000494:pharmacology; D006801:Humans; D007529:Isoflavones; D048789:Phytoestrogens; D028321:Plant Preparations; D011956:Receptors, Cell Surface / Q000187:drug effects / Q000378:metabolism; D011960:Receptors, Estrogen / Q000187:drug effects / Q000378:metabolism
chemical_list: D001559:Benzhydryl Compounds; D020847:Estrogen Receptor Modulators; D047628:Estrogen Receptor alpha; D004967:Estrogens; D004968:Estrogens, Non-Steroidal; D007529:Isoflavones; D048789:Phytoestrogens; D028321:Plant Preparations; D011956:Receptors, Cell Surface; D011960:Receptors, Estrogen; C010129:diphenylmethane